<DOC>
	<DOCNO>NCT00743210</DOCNO>
	<brief_summary>The purpose study determine oral L-citrulline ( 3 grams/day ) 3 week provide mid-pregnancy obese subject decrease plasma ADMA/L-arginine ratio , low maternal blood pressure , improve endothelial-dependent vascular function peripheral vascular stiffness , improve uterine artery Doppler resistance flow .</brief_summary>
	<brief_title>Oral L-Citrulline ADMA Pregnancy</brief_title>
	<detailed_description>The pregnancy-specific syndrome preeclampsia lead cause maternal fetal morbidity mortality . The underlying cause preeclampsia unknown , however several pre-existing maternal condition associate increase risk preeclampsia include : diabetes , hypertension , renal dysfunction , obesity . Among condition , obesity increase population , 30 % adult population US consider obese , obesity large attributable risk preeclampsia , account 15 32 % population attributable risk preeclampsia . There abundant evidence pre-pregnancy obesity increase risk preeclampsia . However , unknown pre-pregnancy obesity increase risk preeclampsia , obesity-mediated metabolic aberration interact current hypothesis pathogenesis preeclampsia , subset obese woman ( ~6-8 % ) develop preeclampsia . Several line evidence indicate endothelial dysfunction central feature pathophysiology preeclampsia , endothelial dysfunction common endpoint obesity . Asymmetric dimethylarginine ( ADMA ) methylated metabolite amino acid L-arginine endogenous inhibitor nitric oxide synthase ( NOS ) . High concentration ADMA contribute endothelial dysfunction ADMA inhibit angiogenesis arteriogenesis , activity important pregnancy deficient preeclampsia . ADMA high obesity ADMA concentration higher early pregnancy among woman later develop preeclampsia . This protocol describe randomize placebo-controlled trial L-citrulline vs. placebo 80 obese pregnant woman twelve twenty week gestation , determine whether L-citrulline supplementation decrease plasma ADMA/L-arginine ratio , lower maternal blood pressure , improve endothelial-dependent vascular function peripheral vascular stiffness , improvement uterine artery Doppler resistance flow . We compare data obtain obese pregnant woman measure obtain 40 untreated lean pregnant woman .</detailed_description>
	<criteria>Prepregnancy body mass index great equal 30kg/m2 Primiparity Singleton pregnancy Gestational age randomization 10 14 week base clinical information evaluation early ultrasound Maternal age 14 40 year chronic hypertension pregestational diabetes medication ( insulin , glyburide ) major fetal anomaly demise plan termination pregnancy collagen vascular disease ( autoimmune disease ) medication renal disease epilepsy seizure disorder active chronic liver disease heart disease cigarette smoker know illicit drug alcohol abuse current pregnancy already take Lcitrulline supplement ( 1gram/day )</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>obesity</keyword>
	<keyword>asymmetric dimethylarginine</keyword>
	<keyword>L-arginine</keyword>
	<keyword>L-citrulline</keyword>
</DOC>